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M A J O R A R T I C L E
Brain-Derived Neurotrophic Factor Protects
against Multiple Forms of Brain Injury
in Bacterial Meningitis
Yoeng-Delphine Bifrare, Ju¨rg Kummer, Philipp Joss, Martin G. Ta¨uber, and Stephen L. Leib
Institute for Infectious Diseases, University of Bern, Bern, Switzerland
Background. Brain-derived neurotrophic factor (BDNF) blocks activation of caspase-3, reduces translocation
of apoptosis-inducing factor (AIF), attenuates excitotoxicity of glutamate, and increases antioxidant enzyme ac-
tivities. The mechanisms of neuroprotection suggest that BDNF may be beneficial in bacterial meningitis.
Methods. To assess a potentially beneficial effect of adjuvant treatment with BDNF in bacterial meningitis,
11-day-old infant rats with experimental meningitis due to Streptococcus pneumoniae or group B streptococci (GBS)
were randomly assigned to receive intracisternal injections with either BDNF (3 mg/kg) or equal volumes (10 mL)
of saline. Twenty-two hours after infection, brains were analyzed, by histomorphometrical examination, for the
extent of cortical and hippocampal neuronal injury.
Results. Compared with treatment with saline, treatment with BDNF significantly reduced the extent of 3
distinct forms of brain cell injury in this disease model: cortical necrosis in meningitis due to GBS (median, 0.0%
[range, 0.0%–33.7%] vs. 21.3% [range, 0.0%–55.3%]; ), caspase-3–dependent cell death in meningitis dueP ! .03
to S. pneumoniae (median score, 0.33 [range, 0.0–1.0] vs. 1.10 [0.10–1.56]; ), and caspase-3–independentP ! .05
hippocampal cell death in meningitis due to GBS (median score, 0 [range, 0–2] vs. 0.88 [range, 0–3.25]; ).P ! .02
The last form of injury was associated with nuclear translocation of AIF.
Conclusion. BDNF efficiently reduces multiple forms of neuronal injury in bacterial meningitis and may hold
promise as adjunctive therapy for this disease.
Despite improved antibiotic treatment, bacterial men-
ingitis remains a devastating disease, with mortality of
up to 30% [1, 2]. The long-term sequelae of bacterial
meningitis are common and include hearing loss, sei-
zures, sensory-motor deficits, and impairment of learn-
ing and memory [3, 4]. A follow-up study of children
revealed that, as late as 12 years after recovery from
bacterial meningitis, significant neurological and intel-
lectual impairments persisted [5]. Streptococcal pneu-
monia is consistently associated with a particularly high
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incidence of neurological sequelae, with up to half of
the survivors presenting some form of neurological se-
quelae [6, 7].
In humans and in experimental animal models, bac-
terial meningitis causes neuronal injury to the cortical
and subcortical regions [8–11]. Three distinct forms of
neuronal cell death have been documented. In the cortex,
neurons undergo ischemic damage, leading to cellular
necrosis in the ischemic core and to caspase-3–depen-
dent cell death in the penumbra [12–15]. Two different
forms of cell death have been identified in the dentate
gyrus of the hippocampus, a region important for learn-
ing and memory: classic caspase-3–dependent cell death
(i.e., apoptosis) primarily affects the subgranular zone
containing recently divided immature neurons, whereas
caspase-3–independent cell death (i.e., pyknosis) occurs
throughout the dentate granular cell layer, affecting both
mature and immature neurons [16].
Neurotrophins, a family of the neurotrophic factors,
control neuronal cell death in development and play
an important role in neuronal differentiation and sur-
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vival [12–15]. Brain-derived neurotrophic factor (BDNF) is of
particular interest, since its receptor (trkB) is found in a broad
range of neuronal cell types and is highly expressed in the hip-
pocampus. Because of its neuroprotective effects, BDNF holds
promise as a treatment for diseases of the central nervous system
(CNS). In several studies of ischemic-hypoxic injury, BDNF ex-
hibited marked antiapoptotic effects by blocking activation of
caspase-3 [17, 18]. Furthermore, BDNF attenuated the nuclear
translocation of apoptosis-inducing factor (AIF) [19], which can
be a mediator of caspase-3–independent cell death.
Given the neuroprotective effect of administration of BDNF
in various models of neuronal injury, we decided to evaluate
the neuroprotective effect of BDNF in experimental meningitis,
using a well-characterized infant rat model that mimics im-
portant features of the human disease and exhibits all 3 forms
of neuronal injury associated with bacterial meningitis [15, 16,
20–23]. We took advantage of the fact that the extent of the
various forms of injury depends on the infecting pathogen.
Bacterial meningitis due to Streptococcus pneumoniae primar-
ily induces apoptosis and, to a much lesser extent, pyknosis,
whereas the reverse is true for meningitis due to group B strep-
tococci (GBS) [16]. Thus, depending on the form of injury
investigated, we used one or the other infecting pathogen to
examine the effect of adjuvant administration of BDNF. The
effect of BDNF on apoptotic cell death in the dentate gyrus of
the hippocampus was analyzed by use of S. pneumoniae as the
infecting pathogen, whereas its effect on caspase-3–independent
cell death and cortical necrosis was analyzed by use of GBS as
the infecting pathogens.
MATERIALS AND METHODS
Infecting pathogens. To maximize the extent of the various
forms of neuronal injury, we used a type III GBS isolate to
examine cortical necrosis and caspase-3–independent cell death
in the dentate gyrus and a serotype 3 S. pneumoniae isolate to
examine hippocampal apoptotic cell death. Both organisms were
initially isolated from patients with bacterial meningitis and
had been passaged repeatedly through animals. The organisms
were grown on blood-agar plates, cultured overnight in 10 mL
of brain-heart infusion medium, diluted in fresh medium, and
grown for 6 h to logarithmic phase. The culture broth was
centrifuged for 10 min at 5000 g, pelleted, resuspended in ster-
ile saline to the desired density, and used for intracisternal
injection. The accuracy of the inoculum size was confirmed by
quantitative cultures.
Model of meningitis. The animal studies were approved by
the Animal Care and Experimentation Committee of the Can-
ton of Bern, Switzerland, and followed National Institutes of
Health guidelines for the performance of animal experiments.
Nursing Sprague-Dawley rat pups ( ) were infected onn p 60
postnatal day 11 by intracisternal injection of 10 mL of saline
containing either S. pneumoniae (log10 cfu/mL;7.5  0.4 n p
) or GBS (log10 cfu/mL; ). Infected rats were20 7.6  0.9 n p 40
randomized for repeated intracisternal injections of either 3
mg/kg BDNF per dose (provided by Regeneron Pharmaceuti-
cals) or equal volumes (10 mL) of saline at 0, 6, 12, 15, 18, and
21 h after infection. Eighteen hours after intracisternal injec-
tion, rats were weighed and assessed clinically, as described
elsewhere [24]. To document meningitis, 10 mL of cerebrospinal
fluid (CSF) was obtained by puncture of the cisterna magna
and was cultured quantitatively by serial dilutions. Infected rats
then received 1 subcutaneous injection of 100 mg/kg ceftriax-
one (Roche Pharma).
Histopathological examination. For histopathological ex-
amination, rats were killed h ( ) after in-22  0.5 mean  SD
fection. Rats that died spontaneously or that had to be killed for
ethical reasons before 21 h after infection were not included
( ). After perfusion with 4% paraformaldehyde in PBS, 12n p 19
coronal sections from the frontal, middle, and dorsal brain region
were mounted on polylysine-coated slides and Nissl stained with
cresyl blue. Forty-one rats were evaluated for cortical and hip-
pocampal injury: 9 were infected with S. pneumoniae and treated
with saline, 7 were infected with S. pneumoniae and treated with
BDNF, 14 were infected with GBS and treated with saline, and
11 were infected with GBS and treated with BDNF.
Cortical necrosis, defined as areas of reduced neuronal den-
sity with neurons displaying morphological features of necrosis,
including cell swelling and loss of cytoarchitecture (figure 1A),
was assessed as a percentage of total cortex, and a mean per-
centage per rat was calculated from all evaluated sections [25].
In the dentate gyrus of the hippocampus, the extent of neuronal
injury was scored by use of bright-field microscopy. Pyknosis,
which is characterized morphologically by uniformly shrunken
nuclei, forming clusters of damaged cells predominantly in the
lower blade of the dentate granule cell layer (figure 1B), was
assessed in the 4 blades of the structure and, if present, was
scored as 1 point for each blade (maximum, 4 points/section)
[16]. The median score for each rat was calculated from all
sections evaluated. For apoptosis, cells with morphological fea-
tures of apoptosis (condensed, fragmented nuclei and apoptotic
bodies) (figure 1C) were counted in 3 visual fields (magnifi-
cation, 400) in each of the 4 blades of the dentate gyrus, and
the following scoring system was applied for the count in each
blade: 0–5 cells, 0; 6–20 cells, 1; and 120 cells, 2 [15]. The
median score per rat was calculated from all sections evaluated.
All histopathological examinations were performed by an in-
vestigator who was unaware of the clinical, microbiological,
and treatment data for the respective rat.
Immunhistochemical analysis. For immunohistochemical
analysis, rats were killed and perfused with PBS, and their brains
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Figure 1. Brain histological examination of the cortex (A) and the dentate gyrus (B and C) in infant rats with bacterial meningitis. A, In the cerebral
cortex, necrotic neuronal loss is present in a wedge-shaped pattern (arrowheads). Insert, Areas of cortical necrosis (right side) are sharply demarcated
from unaffected areas (left side) and show reduced neuronal density and neurons with morphological features of necrosis, including cell swelling,
loss of cellular demarcation, and fading of cytoarchitecture (original magnification, 400; cresyl violet staining). B, Pyknosis in the dentate gyrus of
the hippocampus, containing clustered cells with dense and shrunken nuclei (see insert for magnification 1200), spanning the entire blade of the
dentate gyrus (arrowheads). The lower blade was consistently more severely affected than the upper blade (original magnification, 400; cresyl violet
staining). C, Apoptosis in the subgranular zone. Neurons with condensed and fragmented nuclei (see insert for magnification 1200) are scattered
along the subgranular zone (arrowheads) (original magnification, 400; cresyl violet staining).
Table 1. Effect of treatment with brain-derived neurotrophic factor (BDNF) on cerebrospinal
fluid (CSF) bacterial titers, weight loss, activity score, and mortality in rats with meningitis
due to group B streptococci (GBS) or Streptococcus pneumoniae.
Pathogen, treatment
CSF bacterial titer,
log10 cfu/mL Weight loss, g Activity score Mortality, %
GBS
Saline (n p 22) 7.8  0.9 0.4  0.5 3.9  0.5 36
BDNF (n p 18) 7.3  0.7 1.6  1.0a 3.8  0.5 50
S. pneumoniae
Saline (n p 10) 7.6  0.2 0.5  0.5 3.9  0.2 10
BDNF (n p 10) 7.5  0.5 1.7  0.3a 3.8  0.3 30
NOTE. Data are , except where noted. CSF titers, weight loss, and activity score were evaluatedmean  SD
18 h after infection. Mortality was evaluated within 22 h after infection.
a .P ! .05
were embedded in paraffin. Two-micrometer sections were cut,
mounted, deparaffinized, and hydrated. The sections were
rinsed with PBS, incubated overnight at 4C with the primary
antibody for AIF (provided by G. Kroemer, Institut Gustave
Roussy, France), and diluted 1:200 in antibody buffer (1/1 [vol/
vol] 0.5% bovine serum albumin in PBS and 0.5 mol/L Tris
buffer [pH 7.6] in 0.88% NaCl). Sections were then washed in
PBS and incubated for 1 h at room temperature with the sec-
ondary antibody (Alexa Fluor 488; Molecular Probe), diluted
1:1000 in antibody buffer. Nuclei were counterstained with 4’-
6-diamidino-2-phenylindole (DAPI).
Statistical methods. The clinical parameters were com-
pared by use of the unpaired Student’s t test. Neuronal injury
was analyzed by use of the Mann-Whitney U test. wasP ! .05
considered to be significant.
RESULTS
Characteristics of disease. Eighteen hours after infection, all
rats had documented meningitis, with lethargy and positive
bacterial cultures in CSF. Compared with treatment with saline,
treatment with BDNF had no effect on CSF bacterial titers,
clinical score, or survival (table 1). However, rats treated with
BDNF lost significantly more weight than did rats treated with
saline (table 1). This increased weight loss was presumably due
to the appetite suppression known to be associated with central
application of BDNF [26].
Effect of treatment with BDNF on cortical necrosis. The
effect of treatment with BDNF on ischemic cortical necrosis
was evaluated in rats infected with GBS. Among infected, saline-
treated rats, 11 of 14 showed necrosis (median, 21.3%; range,
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Figure 2. Histomorphometrical analysis of neuronal injury in rats with experimental meningitis treated with saline () or brain-derived neurotrophic
factor (BDNF; ). The bar represents the median value in each group (A–C). BDNF significantly attenuated cortical necrosis (A) and caspase-3–
independent hippocampal cell death (B) in meningitis due to group B streptococci and caspase-3–dependent apoptosis (C) in meningitis due to
Streptococcus pneumoniae.
Figure 3. Immunohistochemical analysis of apoptosis-inducing factor (AIF) in meningitis due to group B streptococci in the hippocampal dentate
gyrus (A). B, Counterstaining with 4’-6-diamidino-2-phenylindole; C, merged picture. In healthy neurons, AIF is located in the cytoplasm (white arrowheads),
whereas, in pyknotic cells, AIF is clearly translocated into the nucleus (black arrowheads) (fluorescence imaging, magnification 600).
0.0%–55.3%). The appearance of cortical injury was charac-
teristic of the patterns described previously in this model [21–
23], with focal, often wedge-shaped areas of neuronal loss (fig-
ure 1A). Treatment with BDNF significantly ( ) reducedP ! .03
the incidence and extent of cortical injury (figure 2A). Only 3
of 11 infected, BDNF-treated rats had cortical injury (median
0.0%; range, 0.0%–33.7%).
Effect of treatment with BDNF on caspase-3–independent
cell death in the hippocampus. Caspase-3–independent cell
death in the hippocampus has previously been reported to be
associated primarily with GBS infection [16]. Accordingly, the
effect of BDNF on this form of injury was assessed in the rats
infected with GBS. Among infected, saline-treated rats, 10 (71%)
of 14 showed evidence of this form of neuronal injury, with a
median score of 0.88 (range, 0–3.25). Treatment with BDNF
significantly reduced this form of hippocampal cell death, with
only 2 (19%) of 11 infected, BDNF-treated rats showing neu-
ronal damage, with a median score of 0 (range, 0–2) ( )P ! .02
(figure 2B).
Nuclear translocation of AIF in caspase-3–independent cell
death. The nature of the caspase-3–independent cell death in
this model of meningitis due to GBS has not been clarified
[16]. Previous studies have suggested that, in bacterial men-
ingitis, some forms of neuronal injury in the hippocampus may
be associated with nuclear translocation of AIF [27]. Since
BDNF can block nuclear translocation of AIF [19] and since
it was effective in reducing caspase-3–independent cell death
in the present study, we reasoned that this form of injury may
be associated with nuclear translocation of AIF. Staining for
AIF by use of fluorescent immunhistochemical analysis doc-
umented the presence of AIF in the cytoplasm of normally
appearing cells in the dentate gyrus. In contrast, in cells that,
by DAPI staining, showed evidence of injury (i.e., condensed,
shrunken, and rounded nuclei), AIF was consistently localized
to the nucleus (figure 3). Thus, the pyknotic form of hippo-
campal neuronal injury in bacterial meningitis is associated
with nuclear translocation of AIF, and BDNF prevents this form
of injury, presumably by inhibiting nuclear translocation of AIF.
Effect of therapy with BDNF on hippocampal apoptosis.
Caspase-3–dependent apoptosis was evaluated in the model of
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meningitis due to S. pneumoniae. As reported elsewhere [16],
infection with S. pneumoniae consistently led to cells showing
apoptotic morphological features in the subgranular zone of
the dentate gyrus. In rats infected with S. pneumoniae and
treated with saline, the median score of apoptotic neurons was
1.10 (range, 0.08–1.56). Treatment with BDNF significantly re-
duced the extent of this form of injury (median score, 0.33;
range, 0.0–1.0; ) (figure 2C).P ! .05
DISCUSSION
Since the discovery of the potent survival-promoting effects of
neurotrophic factors, there has been the hope that they can be
used successfully in treating diseases of the CNS. BDNF is of
particular interest in this regard, since its receptor (trkB) is
expressed in a broad range of neurons throughout the brain
[28], which is a prerequisite for a beneficial effect in diseases
affecting multiple regions of the brain, as is the case in bacterial
meningitis. Several studies have demonstrated the beneficial
effect of BDNF in treating ischemia, trauma, and excitotoxicity
[17, 18, 29, 30]. In the present study, we have demonstrated
that adjuvant therapy with BDNF in experimental bacterial
meningitis protects the brain from 3 distinct forms of injury:
necrosis affecting the cortex and caspase-3–dependent and
–independent cell death in the hippocampal dentate gyrus.
Bacterial meningitis causes wedge-shaped lesions in the cor-
tex, defined by neuronal loss and morphological features of
cellular necrosis (cell swelling and fading of cytoarchitecture)
[25]. The results of several experimental studies have supported
the importance of ischemia as a central mechanism in cortical
necrosis. For example, inhibition of the endogenous vasocon-
strictors endothelins with a nonselective receptor antagonist
(bosentan) protected infant rats with pneumococcal meningitis
from a reduction in cerebral blood flow and simultaneously
reduced cortical injury [25]. Along the same line, inhibition of
the production of the vasodilative nitric oxide with an inhibitor
of inducible nitric oxide synthase (aminoguanidine) reduced
cerebral blood flow and increased cortical necrotic damage [31].
The mechanisms by which BDNF protects from ischemic
injury in bacterial meningitis are not clear. Cellular calcium
overload plays a role in a variety of CNS insults, particularly
in conjunction with excitatory amino acids (EAAs) [32]. BDNF
can enhance the binding capacity of intracellular calcium and
thereby increase cell survival [33]. In bacterial meningitis, levels
of EAAs are increased in interstitial brain fluid [34], and an
antagonist of neuronal EAA receptors (kynurenic acid) atten-
uates cortical injury [22]. Thus, by neutralizing the potentially
detrimental effects of increased intracellular calcium, BDNF
may preserve neurons from necrosis.
A further possible explanation for the beneficial effect of BDNF
in experimental meningitis may be related to its ability to increase
antioxidant enzyme activities and thus attenuate the harmful
effects of reactive oxygen species [30]. Adjuvant antioxidants
reduce cortical injury in models of bacterial meningitis, possibly
through preservation of cerebral blood flow [21, 35].
In the hippocampus, bacterial meningitis causes caspase-3–
dependent apoptosis of neurons, including recently divided im-
mature neurons located in the subgranular zone of the dentate
gyrus [15, 16]. In a neonatal hypoxia-ischemia model, BDNF
has been shown to be protective against caspase-3–dependent
cell death by blocking activation of caspase-3 through the trkB
receptor [18]. Interestingly, this receptor, which mediates pro-
genitor cell survival and neurogenesis, is expressed in the same
region where caspase-3–dependent cell death affects progenitor
cells in meningitis [16]. The inhibitory activity of BDNF on
caspase-3–mediated proapoptotic pathways is likely responsible
for its beneficial effect on caspase-3–dependent cell death in
the present study.
Pyknosis (i.e., caspase-3–independent cell death) is distinct
from apoptosis (i.e., caspase-3–dependent cell death) and is
characterized by cell clusters with dense and shrunken nuclei
that are TUNEL negative and fail to express activated caspase-
3 [16]. In the present study, we found that BDNF also protected
against this form of injury. The beneficial effect of BDNF on
caspase-3–independent cell death has been documented in a
model of retinal detachment in rats, in which cell death was
shown to be induced by the translocation of AIF into the nu-
cleus [19]. Furthermore, a recent study analyzing caspase-3–
independent cell death documented that nuclear translocation
of AIF was triggered by glucose deprivation and ischemia, con-
ditions that frequently affect the brain during meningitis [36].
We therefore explored whether nuclear translocation of AIF
occurred in our model of meningitis due to GBS [16, 27]. In-
deed, pyknotic cells in the dentate gyrus consistently showed
immunocytochemical evidence of AIF in the nucleus. This re-
sult suggests that the protective effect of BDNF against pyknosis
seen in the present model of bacterial meningitis is related to
its capacity to interfere with nuclear translocation of AIF.
In conclusion, BDNF is neuroprotective against 3 distinct
forms of neuronal cell injury in bacterial meningitis. These
findings are of particular interest in light of recent findings that
production of BDNF increases during meningitis at both the
transcriptional and translational level, whereas treatment with
antibiotics reduces production of BDNF [37]. It thus appears
that BDNF is part of an endogenous protective pathway during
meningitis and that external administration in parallel to an-
tibiotic treatment of bacterial meningitis has the potential to
reduce neuronal cell injury and, possibly, long-term neurolog-
ical sequelae.
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